PodParley PodParley
GPH 57: Radiation

EPISODE · Mar 25, 2026 · 36 MIN

GPH 57: Radiation

from Clinical Deep Dives · host Dr Manaan Kar Ray

In this episode, Medlock Holmes steps into a realm that cannot be seen, touched, or smelled - yet profoundly influences human health: radiation.We begin with the electromagnetic spectrum, distinguishing between ionising radiation (X-rays, gamma rays, radioactive particles) and non-ionising radiation (ultraviolet, infrared, radiofrequency, and extremely low-frequency fields). Holmes explains how energy level determines biological impact, from DNA damage to thermal effects.The episode explores sources of exposure:* Natural background radiation* Medical imaging and radiotherapy* Occupational exposures* Nuclear energy* Consumer technologies and telecommunicationsHolmes carefully distinguishes established risks from areas of ongoing scientific uncertainty. Ionising radiation is clearly linked to cancer and genetic damage. Ultraviolet radiation is associated with skin cancer and cataract. For other exposures - such as extremely low-frequency fields or radiofrequency radiation - evidence remains debated and evolving.We examine dose-response relationships, latency periods, occupational cohort studies, and international exposure guidelines. Holmes emphasises risk assessment, precautionary principles, and the balance between technological benefit and health protection.Radiation reminds us that risk is not always visible. Public health must often act based on probability rather than perception.Key Takeaways* Ionising radiation can damage DNA and increase cancer risk.* Non-ionising radiation has varying biological effects depending on frequency and intensity.* Medical exposures require risk–benefit balancing.* Occupational and environmental exposures must be regulated.* Dose and duration determine risk magnitude.* Uncertainty must be communicated transparently.* Radiation policy integrates science, technology, and precaution. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 57: Radiation

0:00 36:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!